Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
As bacteria that cause infection adapt to withstand antibiotics, the potential for antimicrobial resistance to cause a global health crisis looms large. Scientists and policymakers are working together to find ways to fight back against this threat.
The aim of precision oncology is to develop treatments that target the molecular characteristics of an individual’s tumour. This tailored approach to cancer care could be transformative, but currently only a select few people with cancer are benefitting.
New therapies are turning cystic fibrosis, an inherited disorder that causes a vicious cycle of mucus build-up, infection and inflammation, into a more manageable condition that people can survive into adulthood.
The application of science to real-world problems drives economies and improves lives. Nature is shining a spotlight on some of the brightest entrepreneurial ventures by profiling the 12 finalists of The Spinoff Prize – a new competition showcasing start-ups originating in academic labs.
For a disease that is thought to affect more than 250 million people, chronic obstructive pulmonary disease (COPD) has long been overlooked. As prevalence climbs, researchers are working to shed new light on COPD and to meet the growing public-health problem head on.
Researchers are homing in on the myriad ways in which the bacteria and other microorganisms that inhabit the human digestive system affect our health – and how they could point the way towards new therapies.
The ocean is an integral element of our planet’s climate system. Understanding the physical processes at work within the ocean is therefore crucial to making accurate predictions about where climate change is likely to lead.